Cell Impact AB (publ) (STO:CI)
Sweden · Delayed Price · Currency is SEK 0.0568
+0.0016 (2.90%)
Aug 14, 2026, 5:29 PM CET
Cell Impact AB Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 5.29 | 5.69 | 37.92 | 47.66 | 77.71 | 81.8 |
Revenue Growth | -55.58% | -85.01% | -20.44% | -38.67% | -5.00% | 179.09% |
Gross Profit Gross Profit Growth | 0.21 | -4.97 | 6.01 | 25.85 | 37.84 | 34.88 |
Operating Income Operating Income Growth | -121.06 | -127.91 | -99.02 | -119.49 | -103.47 | -78.04 |
Net Income Net Income Growth | -125.35 | -131.98 | -100.43 | -121.4 | -104.22 | -79.85 |
Earnings Per Share EPS Growth | -4.07 | -0.78 | -1.62 | -11.07 | -13.76 | -13.49 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Sweden Sweden Growth | 1.7 | 0.26 | 1 | 1.35 | 0.62 |
Other Europe Other Europe Growth | 1.45 | 5.91 | 0.34 | 0.47 | 0.02 |
US US Growth | 0.9 | 25.05 | 45.01 | 73.1 | 64.18 |
Asia Asia Growth | 1.52 | 6.11 | 0.91 | 1.89 | 6.52 |
Total Total Growth | 5.57 | 37.33 | 47.26 | 76.81 | 71.35 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 0.42 | 10.86 | 20.39 | 99.89 | 164.67 | 28.56 |
Total Debt Total Debt Growth | 13.91 | 26.63 | 30.92 | 42.75 | 44.7 | 19.51 |
Net Cash (Debt) Net Cash Growth | -13.49 | -15.77 | -10.53 | 57.15 | 119.97 | 9.05 |
Net Cash Growth | - | - | - | -52.37% | 1225.78% | -93.04% |
Net Cash Per Share Net Cash Per Share Growth | -0.44 | -0.09 | -0.17 | 5.21 | 15.84 | 1.53 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -34.8 | -45.36 | -62.23 | -105.83 | -105.93 | -86.08 |
Capital Expenditures CapEx Growth | -1.51 | -1.93 | -12.4 | -50.46 | -62.44 | -52.97 |
Free Cash Flow Free Cash Flow Growth | -36.31 | -47.29 | -74.64 | -156.29 | -168.37 | -139.05 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 4.01% | -87.41% | 15.86% | 54.24% | 48.69% | 42.64% |
Operating Margin | -2288.45% | -2249.63% | -261.12% | -250.70% | -133.14% | -95.40% |
Pretax Margin | -2368.83% | -2321.12% | -264.62% | -254.63% | -134.02% | -97.47% |
Profit Margin | -2369.51% | -2321.21% | -264.84% | -254.71% | -134.11% | -97.62% |
FCF Margin | -686.35% | -831.69% | -196.82% | -327.92% | -216.66% | -169.99% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 5.23 | 8.34 | 2.63 | 2.79 | 10.69 | 25.33 |